[1] 龙行涛,周琦. 局部晚期宫颈癌治疗现状与进展[J].中国实用妇科与产科杂志,2017,33(11):1206-1209.
[2] YANG K,PARK W,HUH S J,et al. Clinical outcomes in patients treated with radiotherapy after surgery for cervical cancer[J].Rad Oncol J,2017,35(1):39-47.
[3] KOH W J,ABU-RUSTUM N R,BEAN S,et al. Cervical cancer,version 3.2019,NCCN clinical practice guidelines in oncology[J].JNCCN,2019,17(1):64-84.
[4] 周晖,卢淮武,彭永排,等. 《2015年NCCN宫颈癌临床实践指南》解读[J].中国实用妇科与产科杂志,2015,31(3):185-191.
[5] 张云鹤,张震宇. 早期宫颈癌根治性宫颈切除术治疗新进展[J].中国妇产科临床杂志,2016,17(1):80-82.
[6] SHANBHOGUE A K,KARNAD A B,PRASAD S R,et al. Tumor response evaluation in oncology:current update[J].J Comput Assist Tomogr,2010,34(4):479-484.
[7] YOON M,PARK S Y,SHIN D,et al. A new homogeneity index based on statistical analysis of the dose-volume histogram[J].J Appl Clin Med Phys,2007,8(2):9-17.
[8] 李相生,周纯武,戴景蕊,等. 早期子宫颈癌术后复发或转移的CT诊断[J].中国临床医学影像杂志,2007,18(10):719-721.
[9] 沈铿. 重视妇科恶性肿瘤化疗毒副作用的防治[J].中华妇产科杂志,2011,46(12):881-883.
[10] ARAS S,ÍKIZCELI T,AKTAN M. Dosimetric comparison of three-dimensional conformal radiotherapy(3D-CRT) and intensity modulated radiotherapy techniques(IMRT) with radiotherapy dose simulations for left-sided mastectomy patients[J].Eur J Breast Health,2019,15(2):85-89.
[11] 邓海军,赵艳群,罗文娟,等. 宫颈癌术后IMRT和VMAT放疗技术剂量学研究[J].中华肿瘤防治杂志,2017,24(10):708-713.
[12] 许新明,杨健,刘琦,等. 宫颈癌调强放疗急性骨髓抑制影响因素分析[J].中华肿瘤防治杂志,2019,26(12):871-875.
[13] 倪镌,殷卓敏,袁淑慧,等. 妇科恶性肿瘤患者术后辅助不同方式放疗的对比研究[J].中华妇产科杂志,2017,52(3):168-174.
2022, Vol. 39 
